MLG Wealth Management DBA Pine Grove Financial Group’s AbbVie ABBV Stock Holding History

MLG Wealth Management DBA Pine Grove Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$495K	Buy	+2,166	New	+$493K	0.06%	115

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

MLG Wealth Management DBA Pine Grove Financial Group's ABBV Position: Q4 2025 in Review

MLG Wealth Management DBA Pine Grove Financial Group opened a new position in AbbVie (ABBV) in Q4 2025: 2,166 shares worth $495K. The stake represents 0.06% of the portfolio and ranks #115 among its holdings.

4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

MLG Wealth Management DBA Pine Grove Financial Group held 2,166 shares of AbbVie worth $495K as of Q4 2025.
AbbVie was a new MLG Wealth Management DBA Pine Grove Financial Group position in Q4 2025.
AbbVie made up 0.06% of MLG Wealth Management DBA Pine Grove Financial Group's portfolio in Q4 2025, its #115 holding.
4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on MLG Wealth Management DBA Pine Grove Financial Group's 13F filing for Q4 2025, filed 25 Aug 2026.